Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5650)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2013 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cescon M, Bertuzzo VR, Ercolani G, Ravaioli M, Odaldi F, Pinna AD. Liver transplantation for hepatocellular carcinoma: Role of inflammatory and immunological state on recurrence and prognosis. World J Gastroenterol 2013; 19(48): 9174-9182 [PMID: 24409045 DOI: 10.3748/wjg.v19.i48.9174] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v19/i48/9174.htm |
| Number | Citing Articles |
| 1 |
Leonardo Lorente, Sergio Rodriguez, Pablo Sanz, Pedro Abreu-González, Agustín González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel Barrera. Low Serum Melatonin Levels Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma are Associated with Lower Survival after Liver Transplantation. International Journal of Molecular Sciences 2019; 20(7): 1696 doi: 10.3390/ijms20071696
|
| 2 |
Leonardo Lorente, Sergio Rodriguez, Pablo Sanz, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María Martín, Alejandro Jiménez, Manuel Barrera. Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences 2016; 17(9): 1524 doi: 10.3390/ijms17091524
|
| 3 |
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Katharina Müller, Helmut Friess, Katharina Thrum. The role of preoperative albumin‐bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma. Journal of Surgical Oncology 2019; 120(7): 1126 doi: 10.1002/jso.25721
|
| 4 |
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Manuel A. Barrera. High serum soluble CD40L levels previously to liver transplantation in patients with hepatocellular carcinoma are associated with mortality at one year. Journal of Critical Care 2018; 43: 316 doi: 10.1016/j.jcrc.2017.09.032
|
| 5 |
Riccardo Pravisani, Federico Mocchegiani, Miriam Isola, Dario Lorenzin, Gian Luigi Adani, Vittorio Cherchi, Elda Righi, Giovanni Terrosu, Marco Vivarelli, Andrea Risaliti, Umberto Baccarani. Controlling Nutritional Status score does not predict patients' overall survival or hepatocellular carcinoma recurrence after deceased donor liver transplantation. Clinical Transplantation 2020; 34(3) doi: 10.1111/ctr.13786
|
| 6 |
Mohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio. Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article. Annals of Hepatology 2021; 22: 100249 doi: 10.1016/j.aohep.2020.08.067
|
| 7 |
Alessandra Mazzola, Andrea Costantino, Salvatore Petta, Tommaso Vincenzo Bartolotta, Maurizio Raineri, Rodolfo Sacco, Giuseppe Brancatelli, Calogero Cammà, Giuseppe Cabibbo. Recurrence of hepatocellular carcinoma after liver transplantation: an update. Future Oncology 2015; 11(21): 2923 doi: 10.2217/fon.15.239
|
| 8 |
Media N. Ismael, Justin Forde, Eduardo Milla, Walid Khan, Roniel Cabrera. Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver Transplantation. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/7284040
|
| 9 |
Safak Gül-Klein, Anika Kästner, Philipp Konstantin Haber, Felix Krenzien, Simon Wabitsch, Alexander Krannich, Andreas Andreou, Dennis Eurich, Frank Tacke, David Horst, Johann Pratschke, Moritz Schmelzle. Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections. Journal of Hepatocellular Carcinoma 2021; : 133 doi: 10.2147/JHC.S292010
|
| 10 |
Tyler A. Sandow, Stephen E. Arndt, Abeer A. Albar, Daniel A. DeVun, David S. Kirsch, Juan M. Gimenez, Humberto E. Bohorquez, Patrick J. Gilbert, Paul T. Thevenot, Kelley G. Nunez, Gretchen A. Galliano, Ari J. Cohen, Dennis Kay, Paul M. Gulotta. Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant Cohort. Radiology 2018; 286(3): 1072 doi: 10.1148/radiol.2017170731
|
| 11 |
Haoyu Hu, Shuo Qi, Silue Zeng, Peng Zhang, Linyun He, Sai Wen, Ning Zeng, Jian Yang, Weiqi Zhang, Wen Zhu, Nan Xiang, Chihua Fang. Importance of Microvascular Invasion Risk and Tumor Size on Recurrence and Survival of Hepatocellular Carcinoma After Anatomical Resection and Non-anatomical Resection. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.621622
|
| 12 |
Karim J. Halazun, Marc Najjar, Rita M. Abdelmessih, Benjamin Samstein, Adam D. Griesemer, James V. Guarrera, Tomoaki Kato, Elizabeth C. Verna, Jean C. Emond, Robert S. Brown. Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgery 2017; 265(3): 557 doi: 10.1097/SLA.0000000000001966
|
| 13 |
Gonzalo Sapisochin, Jordi Bruix. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nature Reviews Gastroenterology & Hepatology 2017; 14(4): 203 doi: 10.1038/nrgastro.2016.193
|
| 14 |
Hironori Hayashi, Hiroyuki Takamura, Yoshinao Ohbatake, Shinichi Nakanuma, Hidehiro Tajima, Sachio Fushida, Ichiro Onishi, Takashi Tani, Koichi Shimizu, Tetsuo Ohta. Postoperative changes in neutrophil-to-lymphocyte ratio and platelet count: A simple prognostic predictor for adult-to-adult living donor liver transplantation. Asian Journal of Surgery 2018; 41(4): 341 doi: 10.1016/j.asjsur.2017.02.004
|
| 15 |
Yunjiao Wang, Chuchu Peng, Zhigang Cheng, Ximei Wang, Lei Wu, Jingyi Li, Changsheng Huang, Qulian Guo, Hongwei Cai. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis. International Journal of Surgery 2018; 55: 73 doi: 10.1016/j.ijsu.2018.05.022
|
| 16 |
Darren J. H. Tan, Chloe Wong, Cheng Han Ng, Chen Wei Poh, Sneha Rajiv Jain, Daniel Q. Huang, Mark D. Muthiah. A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity. Journal of Clinical Medicine 2021; 10(2): 238 doi: 10.3390/jcm10020238
|
| 17 |
Arno Kornberg, Linda Kaschny, Jennifer Kornberg, Helmut Friess. Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation. Journal of Hepatocellular Carcinoma 2022; : 649 doi: 10.2147/JHC.S366107
|
| 18 |
Weiwen Chen, Yurong Qiu. Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma. Cell Biochemistry and Biophysics 2015; 72(2): 325 doi: 10.1007/s12013-014-0456-9
|
| 19 |
Yung-Fong Tsai, Fu-Chao Liu, Chun-Yu Chen, Jr-Rung Lin, Huang-Ping Yu. Effect of Mycophenolate Mofetil Therapy on Recurrence of Hepatocellular Carcinoma after Liver Transplantation: A Population-Based Cohort Study. Journal of Clinical Medicine 2021; 10(8): 1558 doi: 10.3390/jcm10081558
|
| 20 |
Nikki Lee, Haiyang Wu, Kevin Ng, Ruibang Luo, Tak-Wah Lam, Chung-Mau Lo, Kwan Man. Transcriptome Analysis of Acute Phase Liver Graft Injury in Liver Transplantation. Biomedicines 2018; 6(2): 41 doi: 10.3390/biomedicines6020041
|
| 21 |
Seong Hoon Kim, Eung Chang Lee, Byung Gon Na, Sang Jae Park. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation. European Journal of Surgical Oncology 2019; 45(2): 180 doi: 10.1016/j.ejso.2018.07.066
|
| 22 |
Arno Kornberg, Martina Schernhammer, Jennifer Kornberg, Helmut Friess, Katharina Thrum. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma. Digestive Diseases and Sciences 2019; 64(1): 269 doi: 10.1007/s10620-018-5296-9
|
| 23 |
Gonzalo Sapisochin, Aisling Barry, Mark Doherty, Sandra Fischer, Nicolas Goldaracena, Roizar Rosales, Moises Russo, Rob Beecroft, Anand Ghanekar, Mamatha Bhat, James Brierley, Paul D. Greig, Jennifer J. Knox, Laura A. Dawson, David R. Grant. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis. Journal of Hepatology 2017; 67(1): 92 doi: 10.1016/j.jhep.2017.02.022
|
| 24 |
Sunyoung Lee, Kyoung Won Kim, Woo Kyoung Jeong, Myeong-Jin Kim, Gi Hong Choi, Jin Sub Choi, Gi-Won Song, Sung-Gyu Lee. Gadoxetic acid–enhanced MRI as a predictor of recurrence of HCC after liver transplantation. European Radiology 2020; 30(2): 987 doi: 10.1007/s00330-019-06424-0
|
| 25 |
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Purificación Cerro, Manuel A. Barrera. Patients with high serum substance P levels previously to liver transplantation for hepatocellular carcinoma have higher risk of one-year liver transplantation mortality. Oncotarget 2018; 9(30): 21552 doi: 10.18632/oncotarget.25097
|
| 26 |
Eleni A. Rekka, Panos N. Kourounakis, Maria Pantelidou. Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design. Current Topics in Medicinal Chemistry 2019; 19(4): 276 doi: 10.2174/1568026619666190129122727
|
| 27 |
Xiang-Qian Gu, Wei-Ping Zheng, Da-Hong Teng, Ji-San Sun, Hong Zheng. Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients. World Journal of Gastroenterology 2016; 22(9): 2749-2759 doi: 10.3748/wjg.v22.i9.2749
|
| 28 |
Leonardo Lorente, Sergio T Rodriguez, Pablo Sanz, Agustín F González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A Barrera. DNA and RNA oxidative damage in hepatocellular carcinoma patients and mortality during the first year of liver transplantation. World Journal of Hepatology 2022; 14(6): 1182-1189 doi: 10.4254/wjh.v14.i6.1182
|
| 29 |
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Antonia Pérez-Cejas, Pedro Abreu-González, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Purificación Cerro, Manuel A. Barrera. Serum total antioxidant capacity prior to liver transplantation for hepatocellular carcinoma is associated with 1-year liver transplantation survival. Journal of International Medical Research 2018; 46(7): 2641 doi: 10.1177/0300060518768150
|
| 30 |
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Agustín F. González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A. Barrera. High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantation. Expert Review of Molecular Diagnostics 2019; 19(7): 635 doi: 10.1080/14737159.2019.1619549
|
| 31 |
Soon Kyu Lee, Sung Won Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon. Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(19): 10271 doi: 10.3390/ijms221910271
|
| 32 |
Leonardo Lorente. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(37): 4230-4242 doi: 10.3748/wjg.v24.i37.4230
|
| 33 |
Umberto Cillo, Tommaso Giuliani, Marina Polacco, Luz Maria Herrero Manley, Gino Crivellari, Alessandro Vitale. Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation. World Journal of Gastroenterology 2016; 22(1): 232-252 doi: 10.3748/wjg.v22.i1.232
|
| 34 |
Valli De Re, Anna Rossetto, Alessandro Rosignoli, Elena Muraro, Vito Racanelli, Maria Lina Tornesello, Aron Zompicchiatti, Alessandro Uzzau. Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.897703
|
| 35 |
Jiang Liu, Chung Mau Lo, Kwan Man. Role of Intrahepatic Regional Immunity in Post-Transplant Cancer Recurrence. Engineering 2022; 10: 57 doi: 10.1016/j.eng.2021.11.012
|
| 36 |
Shuangshuang Li, Xudong Feng, Guodong Cao, Qianhui Wang, Ling Wang, Motoyuki Otsuka. Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis. PLOS ONE 2020; 15(3): e0230879 doi: 10.1371/journal.pone.0230879
|
| 37 |
Christoph Suppan, Vesna Bjelic-Radisic, Marlen La Garde, Andrea Groselj-Strele, Katharina Eberhard, Hellmut Samonigg, Hans Loibner, Nadia Dandachi, Marija Balic. Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-2005-3
|
| 38 |
Leonardo Lorente, Sergio Rodriguez, Pablo Sanz, Pedro Abreu-González, Dácil Díaz, Antonia Moreno, Elisa Borja, María Martín, Alejandro Jiménez, Manuel Barrera. Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2016; 17(4): 500 doi: 10.3390/ijms17040500
|
| 39 |
Cheng-Maw Ho, Hui-Ling Chen, Rey-Heng Hu, Po-Huang Lee. Harnessing immunotherapy for liver recipients with hepatocellular carcinoma: a review from a transplant oncology perspective. Therapeutic Advances in Medical Oncology 2019; 11: 175883591984346 doi: 10.1177/1758835919843463
|
| 40 |
Arno Kornberg, Ulrike Witt, Jennifer Kornberg, Katharina Müller, Helmut Friess, Katharina Thrum. Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma. Biomarkers 2016; 21(2): 152 doi: 10.3109/1354750X.2015.1118548
|